+987.9%
MRNA vs VIAV
+72.0%
+915.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VIAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -2.2% | +15.3% | +12.9% |
| 7D | +20.6% | -14.7% | +35.4% | +19.2% |
| 30D | +27.1% | -37.4% | +64.5% | +19.9% |
| 3M | +353.4% | -27.1% | +380.5% | +340.2% |
| 6M | +446.3% | -44.0% | +490.3% | +433.5% |
| YTD | +776.2% | +64.9% | +711.3% | +504.8% |
| 1Y | +987.9% | +75.3% | +912.6% | +603.4% |
| All | +987.9% | +72.0% | +915.9% | +603.4% |
Cumulative growth
Daily Returns
Daily percentage return beside VIAV.
Daily Out/Under-Performance
Portfolio return minus VIAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VIAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VIAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling